Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001087294-25-000029

Director acquired 75 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2025-11-03 Other acquisition 10b5-1 +6 $2.80 $17 33,174 D
Young Caroline Director 2025-11-04 Other acquisition 10b5-1 +6 $2.82 $17 33,180 D
Young Caroline Director 2025-11-05 Other acquisition 10b5-1 +6 $2.53 $15 33,186 D
Young Caroline Director 2025-11-06 Other acquisition 10b5-1 +3 $2.27 $7 33,189 D
Young Caroline Director 2025-11-07 Other acquisition 10b5-1 +3 $2.19 $7 33,192 D
Young Caroline Director 2025-11-10 Other acquisition 10b5-1 +3 $2.11 $6 33,195 D
Young Caroline Director 2025-11-11 Other acquisition 10b5-1 +3 $2.06 $6 33,198 D
Young Caroline Director 2025-11-12 Other acquisition 10b5-1 +3 $1.99 $6 33,201 D
Young Caroline Director 2025-11-13 Other acquisition 10b5-1 +3 $2.17 $7 33,204 D
Young Caroline Director 2025-11-14 Other acquisition 10b5-1 +3 $2.15 $6 33,207 D
Young Caroline Director 2025-11-17 Other acquisition 10b5-1 +4 $2.17 $9 33,211 D
Young Caroline Director 2025-11-18 Other acquisition 10b5-1 +4 $1.98 $8 33,215 D
Young Caroline Director 2025-11-19 Other acquisition 10b5-1 +4 $2.01 $8 33,219 D
Young Caroline Director 2025-11-20 Other acquisition 10b5-1 +4 $1.99 $8 33,223 D
Young Caroline Director 2025-11-21 Other acquisition 10b5-1 +4 $1.96 $8 33,227 D
Young Caroline Director 2025-11-24 Other acquisition 10b5-1 +4 $2.10 $8 33,231 D
Young Caroline Director 2025-11-25 Other acquisition 10b5-1 +4 $2.21 $9 33,235 D
Young Caroline Director 2025-11-26 Other acquisition 10b5-1 +4 $2.17 $9 33,239 D
Young Caroline Director 2025-11-28 Other acquisition 10b5-1 +4 $2.41 $10 33,243 D
Loading xslF345X05/wk-form4_1764626936.xml…